Company: CHPG
Filing Date: 2025-07-07
Form Type: 10-Q
Source: 0001213900-25-061810
Chunk: 151

Company: ChampionsGate Acquisition Corp
Filing Date: 2025-07-07
Form: 10-Q
Item: Part II, Item 1A
Chunk 151
---
ITEM 1A. RISK FACTORS.

As a smaller reporting company,
we are not required to include risk factors in this Report. However, factors that could cause our actual results to differ materially
from those in this Quarterly Report are any of the risks described in our Prospectus. Any of these factors could result in a significant
or material adverse effect on our results of operations or financial condition. Additional risk factors not presently known to us or that
we currently deem immaterial may also impair our business or results of operations. As of the date of this Quarterly Report, there have
been no material changes to the risk factors disclosed in our Prospectus.

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS
FROM REGISTERED SECURITIES.

Unregistered Sales of Equity Securities

On May 29, 2025, substantially
concurrently with the closing of the initial public offering (the “IPO”) of the Company, the Company completed the private
sale of 230,000 units (the “Private Units”) to ST Sponsor Investment LLC (the “Sponsor HoldCo”), a Cayman Islands
limited liability company which has one member, ST Sponsor Limited, a Cayman Islands exempted company and the Company’s sponsor
(the “Sponsor”). Each Private Unit consists of one Class A Ordinary Share and one right. The Private Units were sold at a
purchase price of $10.00 per Private Units, generating gross proceeds to the Company of $2,300,000. The Private Units are identical to
the Units sold in the IPO, subject to limited exceptions as described in the final prospectus of the Company relating to the IPO (SEC
File No. 333-283689), dated May 27, 2025 and filed with the SEC on May 28, 2025.

The above sales were issued
pursuant to the exemption from registration contained in Section 4(a)(2) of the Securities Act. No commissions were paid in
connection with such sales.

Use of Proceeds

On May 29, 2025, we consummated
the IPO of 7,475,000 Public Units, at a price of $10.00 per Unit, generating gross proceeds of $74,750,000. Simultaneously with the closing
of the IPO, we consummated the sale of 230,000 Private Placement Units, to our sponsor in Private Placement, generating gross proceeds